newsfilter
← Latest News
GlobeNewswire·

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

Appointments strengthen rare-disease commercialization planning and strategic partnering capabilities as Ebstrocel™ advances toward potential commercialization BOCA RATON, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) --